Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Epilepsy × Radiotherapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 218 Breast Neoplasms 193 Lung Neoplasms 182 Glioblastoma 177 Head and Neck Neoplasms 165 Prostatic Neoplasms 151 Squamous Cell Carcinoma of Head and Neck 135 Lymphoma 135 Rectal Neoplasms 120 Central Nervous System Neoplasms 104 Esophageal Neoplasms 103 Leukemia 97 Brain Neoplasms 89 Precursor Cell Lymphoblastic Leukemia-Lymphoma 83 Pancreatic Neoplasms 83 Gliosarcoma 80 Esophageal Squamous Cell Carcinoma 71 Lymphoma, Follicular 70 Neoplasms 69 Lymphoma, Large B-Cell, Diffuse 68 Uterine Cervical Neoplasms 67 Lymphoma, Non-Hodgkin 66 Hodgkin Disease 66 Sarcoma 65 Burkitt Lymphoma 59 Glioma 58 Colorectal Neoplasms 57 Leukemia, Lymphocytic, Chronic, B-Cell 56 Lymphoma, Large-Cell, Immunoblastic 52 Astrocytoma 52

Interventions

Sirolimus 4 LY3295668 erbumine 3 Everolimus 3 Medical Marijuana 2 Anticonvulsants 2 ziprasidone 1 perampanel 1 enzalutamide 1 clevidipine 1 brivaracetam 1 Zolpidem 1 Warfarin 1 Vigabatrin 1 Vecuronium Bromide 1 Vancomycin 1 Tranexamic Acid 1 Topotecan 1 Tobramycin 1 Therapeutic Touch 1 Temozolomide 1 TAS-119 1 Surgical Procedures, Operative 1 Sulfasalazine 1 Spironolactone 1 Sevoflurane 1 Sevelamer 1 Saline Solution 1 Rocuronium 1 Registries 1 Radiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05664464 2024-05-10

GLUGLIO

University of Zurich

Phase 1/2 Recruiting

Epilepsy, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡